TIL Q4 2022 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$62M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$57M

Net Income

-$54M

EPS (Diluted)

$-8.29

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$50M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$482M

Total Liabilities

$119M

Stockholders' Equity

$364M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$57M	-$54M	-5.7%
Net Income	-$54M	-$55M	+2.7%